Jiangsu Hualan New Pharmaceutical MaterialLtd Balance Sheet Health
Financial Health criteria checks 6/6
Jiangsu Hualan New Pharmaceutical MaterialLtd has a total shareholder equity of CN¥2.3B and total debt of CN¥473.0K, which brings its debt-to-equity ratio to 0.02%. Its total assets and total liabilities are CN¥2.6B and CN¥235.5M respectively. Jiangsu Hualan New Pharmaceutical MaterialLtd's EBIT is CN¥59.2M making its interest coverage ratio -1.3. It has cash and short-term investments of CN¥810.9M.
Key information
0.02%
Debt to equity ratio
CN¥473.00k
Debt
Interest coverage ratio | -1.3x |
Cash | CN¥810.91m |
Equity | CN¥2.33b |
Total liabilities | CN¥235.46m |
Total assets | CN¥2.56b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 301093's short term assets (CN¥1.8B) exceed its short term liabilities (CN¥153.7M).
Long Term Liabilities: 301093's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥81.8M).
Debt to Equity History and Analysis
Debt Level: 301093 has more cash than its total debt.
Reducing Debt: 301093's debt to equity ratio has reduced from 47.1% to 0.02% over the past 5 years.
Debt Coverage: 301093's debt is well covered by operating cash flow (53288.9%).
Interest Coverage: 301093 earns more interest than it pays, so coverage of interest payments is not a concern.